Ex-GSK rare disease head moves to Genenta – FierceBiotech
FierceBiotech |
Ex-GSK rare disease head moves to Genenta
FierceBiotech He joins Milan, Italy-based Genenta Science, a biotech focused on hematopoietic stem cell gene therapy in cancer, as its new CMO. Russo has worked on gene therapy before as he was head of R&D at London-based GSK's rare disease unit, helping get its … |
